What is the official website of Connect In Pharma ?

The official website of Connect In Pharma is https://www.connectinpharma.com/.

What is Connect In Pharma's cybersecurity risk score?

Connect In Pharma has an AI-generated cybersecurity risk score of 770 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Connect In Pharma experienced?

According to Rankiteo, Connect In Pharma currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Connect In Pharma been affected by any supply chain cyber incidents ?

According to Rankiteo, Connect In Pharma has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Connect In Pharma have SOC 2 Type 1 certification ?

According to Rankiteo, Connect In Pharma is not certified under SOC 2 Type 1.

Does Connect In Pharma have SOC 2 Type 2 certification ?

According to Rankiteo, Connect In Pharma does not hold a SOC 2 Type 2 certification.

Does Connect In Pharma comply with GDPR ?

According to Rankiteo, Connect In Pharma is not listed as GDPR compliant.

Does Connect In Pharma have PCI DSS certification ?

According to Rankiteo, Connect In Pharma does not currently maintain PCI DSS compliance.

Does Connect In Pharma comply with HIPAA ?

According to Rankiteo, Connect In Pharma is not compliant with HIPAA regulations.

Does Connect In Pharma have ISO 27001 certification ?

According to Rankiteo,Connect In Pharma is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Connect In Pharma operate in ?

Connect In Pharma operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Connect In Pharma have ?

Connect In Pharma employs approximately None employees people worldwide.

Does Connect In Pharma own any subsidiaries ?

Connect In Pharma presently has no subsidiaries across any sectors.

How many LinkedIn followers does Connect In Pharma have ?

Connect In Pharma's official LinkedIn profile has approximately followers.

What is the NAICS classification code for Connect In Pharma ?

Connect In Pharma is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Connect In Pharma have a Crunchbase profile ?

No, Connect In Pharma does not have a profile on Crunchbase.

Does Connect In Pharma have a LinkedIn profile ?

Yes, Connect In Pharma maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/connectinpharma.

How many cybersecurity incidents has Connect In Pharma experienced ?

As of September 1, 2026, Rankiteo reports that Connect In Pharma has not experienced any cybersecurity incidents.

How many peer or competitor companies does Connect In Pharma have ?

Connect In Pharma has an estimated 5,747 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Boost Score +25 with badge (5 left)

770

/1000

Fair

795

/1000

Fair

Connect In Pharma Vendor Cyber Rating & Cyber Score

connectinpharma.com

Add Your Compliance Badge

Connect in Pharma is the new event driving innovation for pharma and biopharma businesses Putting patients at the centre, Connect in Pharma will bring together the key players in pharmaceutical and biopharmaceutical production in the heart of Europe’s pharma industry – Geneva. We are your international one-stop-platform for the development, industrialization and contract manufacturing of drug delivery systems and pack & filling technology. From the concept phase to the finished product, every aspect of Connect In Pharma is designed to inspire collaboration and innovation between packaging suppliers, drug delivery systems, CMO/CDMO and filling & assembling processes. With talks, workshops, curated networking and the latest products from

CP A.I CyberSecurity Scoring

Scoring History

Connect In Pharma CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

CP Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for CP

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Connect In Pharma in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Connect In Pharma in 2026.

Incident Types CP vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Connect In Pharma in 2026.

Incident History - CP (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Connect In Pharma Subsidiaries

CP

Pharmaceutical Manufacturing

Website: https://www.connectinpharma.com/

Company Size: 501-1,000 employees

130

EasyfairsEvents Services

Packaging Innovations & EmpackEvents Services

Easyfairs NetherlandsEvents Services

Recreatie VakbeursRecreatievoorzieningen

Dental ExpoEvenementenservices

Infra RelatiedagenEvenementenservices

EmpackNLEvenementenservices

Aqua NederlandEvenementenservices

Maritime IndustryEvenementenservices

HortiContactEvenementenservices

Visualize ExpoEvenementenservices

Futurebuild HollandBouw

De Groene Sector VakbeursEvenementenservices

METAVAKEvenementenservices

Packaging Innovations NLEvenementenservices

Vakbeurs RecyclingEvenementenservices

InCoDaEvenementenservices

Installatie VakdagenEvenementenservices

Rundvee & Mechanisatie VakdagenEvenementenservices

Horeca VakbeursEvenementenservices

Vakbeurs Auto ProfProductie motorvoertuigen

VelovakEvenementenservices

Pumps & Valves RotterdamEvenementenservices

Solids RotterdamEvenementenservices

Recreatie Next LevelEvenementenservices

Dutch Pork ExpoEvenementenservices

Afbouw VakdagenEvenementenservices

Maintenance GorinchemEvenementenservices

Huis & Woon BeursEvenementenservices

Vakbeurs Logistics & AutomationTransport, logistiek, supplychain en opslag

Welding Week NederlandEvenementenservices

Worksafe GorinchemEvenementenservices

The Hair X-perienceEvenementenservices

Schilders VakdagenEvenementenservices

Bouw RelatiedagenEvenementenservices

Tuin & Park ExpoEvenementenservices

Beauty DaysEvenementenservices

M+R RotterdamEvenementenservices

Automation NederlandEvenementenservices

De Dag van het AmbachtEvents Services

Dutch Pork & Poultry ExpoEvenementenservices

InfraNXTEvents Services

Elektro VakbeursEvenementenservices

Vakbeurs Bakkersvak & IJs-VakEvenementenservices

TrendzEvenementenservices

Future LightingEvenementenservices

Advanced Engineering UKEvents Services

Easyfairs BelgiumEvents Services

Loading…

Connect In Pharma Similar Companies

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

PT Kalbe Farma, Tbk

kalbe.co.id

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Loading…

NEWS

Connect In Pharma CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

January 04, 2026 08:00 AM

Healthcare Data Breach Statistics

In 2023, 725 data breaches were reported to OCR and across those breaches, more than 133 million records were exposed or impermissibly disclosed.

Read Article

September 25, 2025 07:00 AM

Cybersecurity: Indispensable for the digital future of the pharmaceutical industry

Cybersecurity in pharma is not just about preventing incidents but about creating a secure foundation for innovation and growth.

Read Article

April 14, 2025 07:00 AM

ResolverRAT Campaign Targets Healthcare, Pharma via Phishing and DLL Side-Loading

Cybersecurity researchers have discovered a new, sophisticated remote access trojan called ResolverRAT that has been observed in attacks...

Read Article

January 30, 2025 08:00 AM

US FDA identifies cybersecurity risks in certain patient monitors

The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with certain patient...

Read Article

January 03, 2025 08:00 AM

Article | Biden to sign cybersecurity executive order next week

President Joe Biden will sign an executive order next week mandating that federal agencies buy internet-connected equipment with a cybersecurity label by 2027.

Read Article

June 29, 2022 07:00 AM

Pharma giant Bayer to set up cybersecurity center in Israel

Pharmaceutical giant Bayer will open a cybersecurity development center in Israel, as part of the German multinational's global cybersecurity operations.

Read Article

September 17, 2021 07:00 AM

Pharma cyber attacks: five breaches that the industry must learn from

Five pharma cybersecurity breaches to know and learn from. The transition to digital, expedited by the Covid-19 pandemic, has opened up new cybersecurity...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-83524

SUMMARY

A security vulnerability has been detected in RedPort Optimizer wXa-203, Optimizer wXa-213 and Optimizer wXa-223 up to 20260704. This impacts the function exec of the file /xgatev1/system/datetime.php of the component System Clock. The manipulation leads to command injection. The attack may be initiated remotely. The exploit has been disclosed publicly and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-08-31

Updated

Date2026-08-31

RISK INFORMATION (Score: 9.9)

cvss2

Base Score: 9.0

Complexity: LOW

AV:N/AC:L/Au:S/C:C/I:C/A:C

cvss3

Base Score: 9.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.1

REFERENCES

CVE-2026-82971

SUMMARY

A vulnerability was determined in QVidium Opera11 3.3.2a26-Ax4x-opera11. This affects an unknown part of the file /cgi-bin/net_tr.cgi of the component CGI Script. This manipulation of the argument ipaddr causes command injection. The attack may be initiated remotely. The exploit has been publicly disclosed and may be utilized. The vendor explains: "QVidium has now closed its doors and no longer will be able to sell products or provide support." This vulnerability only affects products that are no longer supported by the maintainer.

Published

Date2026-08-31

Updated

Date2026-08-31

RISK INFORMATION (Score: 10)

cvss2

Base Score: 10.0

Complexity: LOW

AV:N/AC:L/Au:N/C:C/I:C/A:C

cvss3

Base Score: 10.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.9

REFERENCES

CVE-2026-82957

SUMMARY

A vulnerability was found in hyperledger-firefly firefly up to 1.4.0. The impacted element is the function ValidateOptions of the file internal/events/webhooks/webhooks.go of the component Webhook Subscription. Performing a manipulation of the argument url results in server-side request forgery. Remote exploitation of the attack is possible. The exploit has been made public and could be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-08-31

Updated

Date2026-08-31

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-82954

SUMMARY

A vulnerability was detected in Dokploy up to 0.29.7. This issue affects the function writeTraefikConfigInPath of the file packages/server/src/utils/traefik/application.ts of the component Settings. The manipulation of the argument path results in path traversal. The attack can be launched remotely. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-08-31

Updated

Date2026-08-31

RISK INFORMATION (Score: 9.9)

cvss2

Base Score: 9.0

Complexity: LOW

AV:N/AC:L/Au:S/C:C/I:C/A:C

cvss3

Base Score: 9.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.1

REFERENCES

CVE-2026-82922

SUMMARY

A security vulnerability has been detected in ShopEx ECShop up to 2.5.1. This vulnerability affects the function flow_update_cart of the file /flow.php?step=update_cart. The manipulation of the argument rec_id leads to sql injection. The attack can be initiated remotely. The exploit has been disclosed publicly and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-08-31

Updated

Date2026-08-31

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…